Abstract

Aim . To assess cardiovascular remodeling in patients with diabetic cardiomyopathy (DCM) and compare it with healthy individuals. Material and methods . Among outpatients with newly diagnosed type 2 diabetes (T2D), according to inclusion and exclusion criteria, a group of participants with diabetic cardiomyopathy (DCM) with left ventricular diastolic dysfunction (LV DD) was made before treatment. The second group consisted of healthy individuals of the corresponding age. The structural and functional state of the heart was studied using echocardiography and determination of the N-terminal prohormone of the brain natriuretic peptide (Nt-proBNP) in the blood; of the arteries — using volume sphygmoplethysmography. Markers of fibrosis were determined in the blood: tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) and C-terminal telopeptide 1 (CTP-1). Results . The DMC prevalence in patients with newly diagnosed T2D was 18,7%. LV DD was associated not only with T2D, but also with obesity (r=0,48; p=0,029), blood pressure even in the normal range ((r=0,42; p=0,031 for systolic blood pressure; (r=0,39; p=0,042) for diastolic blood pressure). The Nt-proBNP levels in the normal range and TIMP-1 were higher in the DCM group compared with the group of healthy individuals (p<0,001 and p<0,001, respectively). CTP-1 was lower in the first group compared with the second (p<0,001). In the DCM group, a higher cardioankle vascular index (CAVI1) was recorded compared to the group of healthy individuals (p<0,001). Conclusion . LV DD cannot be presented as a pathognomonic criterion for DCM. Nt-proBNP levels in the normal range of 76,23+14,47 pg/ml, which do not reach the diagnostic criteria for heart failure, an increase in TIMP-1 and a decrease in CTP-1 can be considered as additional markers of DCM. Given the fact that two parallel processes occur during the DCM formation, manifested by cardiac and arteries’ remodeling, the CAVI1 can also be considered as an additional DCM marker.

Highlights

  • The Nt-proBNP levels in the normal range and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) were higher in the diabetic cardiomyopathy (DCM) group compared with the group of healthy individuals (p

  • C-terminal telopeptide 1 (CTP-1) was lower in the first group compared with the second (p

  • left ventricular diastolic dysfunction (LV DD) cannot be presented as a pathognomonic criterion for DCM

Read more

Summary

Introduction

Всего обследовано 123 больных с вновь выявленным СД 2 типа трудоспособного возраста, среди которых была выделена группа из 35 (28,5%) человек с клиническими критериями ДКМ по Aneja A, et al [3], которые исключают наличие АГ и струк‐ турных изменений сердца, таких как патология кла‐ панного аппарата или ИБС. Из таблицы 1 видно, что в группе больных с ДКМ при тканевой визуализации диастолических скоро‐ стей движения фиброзного кольца митрального кла‐ пана все показатели были статистически выше, чем у больных второй группы.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.